In this current study, we observed that silibinin can exhibit varied effects on PIK3CA expression at different inhibitory concentrations (Fig. 2B), aligning with the results of Jahanafrooz et al., who documented diverse inhibitory effects of silibinin in breast cancer cells [24]. Here, PIK3CA is linked to breast cancer.